Agent Technology definition

Agent Technology means the Moderna Agent Technology and the Merck Agent Technology.

Split View

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Get StartedBook a Demo

Agent Technology shall have the meaning set forth in the Marketing Agreement.

Agent Technology means all proprietary information with respect to any Agent and improvements (as defined below) thereto, including, without limitation, all information provided by AM pursuant to Article 6 of this Agreement, Project Information, trade secrets, technical information, data, techniques, discoveries, inventions, processes, know-how, patents (including any extension, reissue or renewal thereof) and patent applications (including such patents and patent applications set forth in EXHIBIT A to this Agreement and incorporated herein), that AM now has or may hereafter conceive, develop, own or Control during the term of this Agreement (but excluding any information owned or Controlled by any Person who becomes a successor or assignee of AM hereunder immediately prior to becoming a successor or assign), which is necessary or useful in connection with: the performance of the Cytogen Project, the marketing and sale by Cytogen of Agent pursuant to Section 4.1 or 4.2 or the performance by Cytogen of its obligations hereunder. No Manufacturing Technology shall be deemed to be included in Agent Technology. For purposes of this Section 1.4, a substance shall only be deemed an "improvement" to the extent that it is an MRI contrast agent composed of the same active ingredient contained in the Agent to which it would be an improvement and falls within the claims of any Patent covering such Agent.

Examples of Agent Technology in a sentence

• Accordingly, Moderna will promptly disclose to Merck in writing, the conception, creation or discovery of any Merck Agent Technology [***] by or on behalf of Moderna or its Affiliates.

• Moderna, for itself and on behalf of its Affiliates, hereby assigns (and to the extent such assignment can only be made in the future hereby agrees to assign), to Merck all its right, title and interest in and to any Merck Agent Technology [***].

• Accordingly, Merck will promptly disclose to Moderna in writing, the conception, creation, or the discovery, of any Moderna Agent Technology, [***] by or on behalf of Merck or its Affiliates.

• Merck, for itself and on behalf of its Affiliates, hereby assigns (and to the extent such assignment can only be made in the future hereby agrees to assign) to Moderna all its right, title and interest in and to any Moderna Agent Technology, [***].

• Merck shall have the sole right, but not the obligation, at its own expense and using counsel of its own choosing, to Prosecute and Maintain the Merck General Patents and any Patents within the Merck Agent Technology worldwide.

• Subject to the terms and conditions contained in this Agreement, AM hereby grants to Cytogen and its Affiliates (a) the non-exclusive right to use the Agent Technology for purposes of performing the Cytogen Project; (b) the exclusive right and license to distribute, market, offer to sell and sell Combidex in the Territory; and (c) the exclusive right and license to distribute, market, offer to sell and sell Code 7228 in the Territory for the Field of Use.

• Notwithstanding anything in this Agreement to the contrary, Moderna has the sole right to enforce and defend all Patents within the Moderna Agent Technology, and Merck has the sole right to enforce and defend all Patents within the Merck Agent Technology.

• The assignment of the 2017 RTC receivable was canceled at the request of the Company, which, after having repaid the Predirec fund, was able to obtain the return of the guarantee deductions and the collection of the totality of its 2017 RTC for €1.9 million.

• Vyripharm has reformulated the use of its In-Situ Hydrogel, N4 Technology and Oligosaccharide (Dual Agent) Technology to develop applications in combination with medical cannabinoids for nuclear imaging and therapeutic applications for neurologic disorders including, but not limited to, post-traumatic stress disorder , epilepsy and other acute/chronic disorders, such as in cancers, metabolic disorders, and microbiome.

• Cytogen and AM shall promptly notify each other of any infringement or misappropriation of any patent or proprietary right that forms part of the Agent Technology or Manufacturing Technology and shall provide each other with any available evidence of such infringement or misappropriation.

More Definitions of Agent Technology

Agent Technology means all proprietary information with respect to any Agent and improvements (as defined below) thereto, including, without limitation, all information provided by AM pursuant to Article 6 of this Agreement, Project Information, trade secrets, technical information, data, techniques, discoveries, inventions, processes, know-how, patents (including any extension, reissue or renewal thereof) and patent applications (including such patents and patent applications set forth in Exhibit A to this Agreement and incorporated herein), that AM now has or may hereafter conceive, develop, own or Control during the term of this Agreement (but excluding any information owned or Controlled by any Person who becomes a successor or assignee of AM hereunder immediately prior to becoming a successor or assign), which is necessary or useful in connection with: the performance of the Cytogen Project, the marketing and sale by Cytogen of Agent pursuant to Section 4.1 or 4.2 or the performance by Cytogen of its obligations hereunder. No Manufacturing Technology shall be deemed to be included in Agent Technology. For purposes of this Section 1.4, a substance shall only be deemed an "improvement" to the extent that it is an MRI contrast agent composed of the same active ingredient contained in the Agent to which it would be an improvement and falls within the claims of any Patent covering such Agent. 1.5 "AM Projects" shall mean the Combidex Project and the Code 7228 Project. 1.6 "Approved Sublicensee" shall mean any Person to whom Cytogen has sublicensed all or a part of its rights arising under this Agreement with AM's written consent, subject to Section 4.4. 1.7 "Feridex Agreement" shall mean the agreement by and between AM and a Third Party under which AM has granted exclusive marketing rights in the Territory to such Third Party. 1.8 "Code 7228" shall mean the contrast agent currently known as Code 7228 which is composed of the substance AMI-7228 and which (i) is covered in whole or in part by an issued, unexpired claim of one or more of the Patents or is manufactured using a process which is covered in whole or in part by an issued, unexpired claim of one or more of the Patents or (ii) is covered by the Agent Technology. 1.9 "Code 7228 Approval Date" shall mean the later of (a) the date of AM's receipt of an FDA approval letter permitting commercial marketing of Code 7228 in the United States (said date being referred to as the "Code 7228 Approval Letter Date") and (b) the d...

Agent Technology means all proprietary